Template:Paracentesis if coagulopathic: Difference between revisions
(Created page with "===Paracentesis if coagulopathic=== *Coagulation studies are NOT required before performance of the procedure<ref>Wilkerson, Ann...") |
|||
| Line 2: | Line 2: | ||
*Coagulation studies are NOT required before performance of the procedure<ref>Wilkerson, Annals of Emerg Med, 2009</ref> | *Coagulation studies are NOT required before performance of the procedure<ref>Wilkerson, Annals of Emerg Med, 2009</ref> | ||
*No data supports cutoff values beyond which paracent should be avoided/prophylactically transfused | *No data supports cutoff values beyond which paracent should be avoided/prophylactically transfused | ||
*Routine use of FFP and platelets is not recommended | *Routine use of [[FFP]] and [[platelets]] is not recommended | ||
*Contraindicated if the patient is actively bleeding or in [[DIC]] and the incidence of clinically significant bleeding complications is low even if in liver failure with an elevated INR (< 0.2%)<ref>Thomsen TW. Paracentesis. N Engl J Med 2006; 355: e21</ref> | *Contraindicated if the patient is actively bleeding or in [[DIC]] and the incidence of clinically significant bleeding complications is low even if in liver failure with an elevated INR (< 0.2%)<ref>Thomsen TW. Paracentesis. N Engl J Med 2006; 355: e21</ref> | ||
Revision as of 08:34, 30 May 2015
Paracentesis if coagulopathic
- Coagulation studies are NOT required before performance of the procedure[1]
- No data supports cutoff values beyond which paracent should be avoided/prophylactically transfused
- Routine use of FFP and platelets is not recommended
- Contraindicated if the patient is actively bleeding or in DIC and the incidence of clinically significant bleeding complications is low even if in liver failure with an elevated INR (< 0.2%)[2]